JACQUES BOGART (JBOG.PA) Fundamental Analysis & Valuation

EPA:JBOG • FR0012872141

3.08 EUR
+0.14 (+4.76%)
Last: Mar 6, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership

This JBOG.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to JBOG. JBOG was compared to 15 industry peers in the Personal Care Products industry. Both the profitability and financial health of JBOG have multiple concerns. JBOG does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

2

1. JBOG.PA Profitability Analysis

1.1 Basic Checks

  • In the past year JBOG has reported negative net income.
  • In the past year JBOG had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: JBOG reported negative net income in multiple years.
  • In the past 5 years JBOG always reported a positive cash flow from operatings.
JBOG.PA Yearly Net Income VS EBIT VS OCF VS FCFJBOG.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

1.2 Ratios

  • JBOG has a Return On Assets of -2.76%. This is amonst the worse of the industry: JBOG underperforms 80.00% of its industry peers.
  • JBOG has a Return On Equity of -15.28%. This is amonst the worse of the industry: JBOG underperforms 86.67% of its industry peers.
  • With a Return On Invested Capital value of 3.44%, JBOG is not doing good in the industry: 86.67% of the companies in the same industry are doing better.
  • JBOG had an Average Return On Invested Capital over the past 3 years of 3.93%. This is significantly below the industry average of 11.43%.
Industry RankSector Rank
ROA -2.76%
ROE -15.28%
ROIC 3.44%
ROA(3y)-0.56%
ROA(5y)-0.18%
ROE(3y)-2.67%
ROE(5y)-0.98%
ROIC(3y)3.93%
ROIC(5y)3.68%
JBOG.PA Yearly ROA, ROE, ROICJBOG.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

  • JBOG's Operating Margin of 4.17% is on the low side compared to the rest of the industry. JBOG is outperformed by 93.33% of its industry peers.
  • In the last couple of years the Operating Margin of JBOG has remained more or less at the same level.
  • JBOG's Gross Margin of 52.35% is on the low side compared to the rest of the industry. JBOG is outperformed by 66.67% of its industry peers.
  • JBOG's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 4.17%
PM (TTM) N/A
GM 52.35%
OM growth 3Y13.73%
OM growth 5Y-1.44%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.87%
GM growth 5Y1.91%
JBOG.PA Yearly Profit, Operating, Gross MarginsJBOG.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. JBOG.PA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so JBOG is destroying value.
  • JBOG has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, JBOG has less shares outstanding
  • JBOG has a worse debt/assets ratio than last year.
JBOG.PA Yearly Shares OutstandingJBOG.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
JBOG.PA Yearly Total Debt VS Total AssetsJBOG.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

  • JBOG has an Altman-Z score of 1.36. This is a bad value and indicates that JBOG is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.36, JBOG is doing worse than 80.00% of the companies in the same industry.
  • The Debt to FCF ratio of JBOG is 9.45, which is on the high side as it means it would take JBOG, 9.45 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of JBOG (9.45) is worse than 80.00% of its industry peers.
  • JBOG has a Debt/Equity ratio of 2.82. This is a high value indicating a heavy dependency on external financing.
  • JBOG has a worse Debt to Equity ratio (2.82) than 93.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.82
Debt/FCF 9.45
Altman-Z 1.36
ROIC/WACC0.69
WACC4.97%
JBOG.PA Yearly LT Debt VS Equity VS FCFJBOG.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

  • JBOG has a Current Ratio of 1.29. This is a normal value and indicates that JBOG is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of JBOG (1.29) is comparable to the rest of the industry.
  • A Quick Ratio of 0.39 indicates that JBOG may have some problems paying its short term obligations.
  • JBOG has a worse Quick ratio (0.39) than 93.33% of its industry peers.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 0.39
JBOG.PA Yearly Current Assets VS Current LiabilitesJBOG.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. JBOG.PA Growth Analysis

3.1 Past

  • JBOG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -269.58%.
  • Looking at the last year, JBOG shows a decrease in Revenue. The Revenue has decreased by -4.04% in the last year.
  • JBOG shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.99% yearly.
EPS 1Y (TTM)-269.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-180.89%
Revenue 1Y (TTM)-4.04%
Revenue growth 3Y5.51%
Revenue growth 5Y-0.99%
Sales Q2Q%-8.53%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
JBOG.PA Yearly Revenue VS EstimatesJBOG.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
JBOG.PA Yearly EPS VS EstimatesJBOG.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 0.1 0.2 0.3 0.4 0.5

More info and screens

Find the best growth stocksShow best growing peers

2

4. JBOG.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • JBOG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
JBOG.PA Price Earnings VS Forward Price EarningsJBOG.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • 100.00% of the companies in the same industry are more expensive than JBOG, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, JBOG is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 2.1
EV/EBITDA 4.81
JBOG.PA Per share dataJBOG.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. JBOG.PA Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 5.00%, JBOG is a good candidate for dividend investing.
  • In the last 3 months the price of JBOG has falen by -32.46%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
  • Compared to an average industry Dividend Yield of 1.77, JBOG pays a better dividend. On top of this JBOG pays more dividend than 100.00% of the companies listed in the same industry.
  • JBOG's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 5%

5.2 History

  • The dividend of JBOG has a limited annual growth rate of 0.04%.
Dividend Growth(5Y)0.04%
Div Incr Years1
Div Non Decr Years2
JBOG.PA Yearly Dividends per shareJBOG.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

  • The earnings of JBOG are negative and hence is the payout ratio. JBOG will probably not be able to sustain this dividend level.
DP-29.81%
EPS Next 2YN/A
EPS Next 3YN/A
JBOG.PA Yearly Income VS Free CF VS DividendJBOG.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

More info and screens

Find the best dividend stocksShow peers with best dividend

JBOG.PA Fundamentals: All Metrics, Ratios and Statistics

JACQUES BOGART

EPA:JBOG (3/6/2026, 7:00:00 PM)

3.08

+0.14 (+4.76%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)02-05
Earnings (Next)N/A
Inst Owners0.15%
Inst Owner ChangeN/A
Ins Owners0.49%
Ins Owner ChangeN/A
Market Cap48.33M
Revenue(TTM)278.19M
Net Income(TTM)-9.83M
Analysts85.71
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 5%
Yearly Dividend0.2
Dividend Growth(5Y)0.04%
DP-29.81%
Div Incr Years1
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.17
P/FCF 2.1
P/OCF 1.77
P/B 0.75
P/tB 2.25
EV/EBITDA 4.81
EPS(TTM)-0.67
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.47
FCFY47.72%
OCF(TTM)1.74
OCFY56.65%
SpS17.73
BVpS4.1
TBVpS1.37
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -2.76%
ROE -15.28%
ROCE 5.08%
ROIC 3.44%
ROICexc 3.73%
ROICexgc 4.59%
OM 4.17%
PM (TTM) N/A
GM 52.35%
FCFM 8.29%
ROA(3y)-0.56%
ROA(5y)-0.18%
ROE(3y)-2.67%
ROE(5y)-0.98%
ROIC(3y)3.93%
ROIC(5y)3.68%
ROICexc(3y)4.95%
ROICexc(5y)5.05%
ROICexgc(3y)6.26%
ROICexgc(5y)6.5%
ROCE(3y)5.59%
ROCE(5y)5.24%
ROICexgc growth 3Y12.53%
ROICexgc growth 5Y-0.27%
ROICexc growth 3Y13.27%
ROICexc growth 5Y-1.06%
OM growth 3Y13.73%
OM growth 5Y-1.44%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.87%
GM growth 5Y1.91%
F-Score4
Asset Turnover0.78
Health
Industry RankSector Rank
Debt/Equity 2.82
Debt/FCF 9.45
Debt/EBITDA 3.86
Cap/Depr 12.21%
Cap/Sales 1.55%
Interest Coverage 250
Cash Conversion 58.31%
Profit Quality N/A
Current Ratio 1.29
Quick Ratio 0.39
Altman-Z 1.36
F-Score4
WACC4.97%
ROIC/WACC0.69
Cap/Depr(3y)18.79%
Cap/Depr(5y)19.78%
Cap/Sales(3y)2.09%
Cap/Sales(5y)2.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-269.58%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-180.89%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-4.04%
Revenue growth 3Y5.51%
Revenue growth 5Y-0.99%
Sales Q2Q%-8.53%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-47.94%
EBIT growth 3Y19.99%
EBIT growth 5Y-2.42%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y26.03%
FCF growth 3Y-5.9%
FCF growth 5Y0.49%
OCF growth 1Y16.22%
OCF growth 3Y-7.79%
OCF growth 5Y0.93%

JACQUES BOGART / JBOG.PA FAQ

What is the ChartMill fundamental rating of JACQUES BOGART (JBOG.PA) stock?

ChartMill assigns a fundamental rating of 2 / 10 to JBOG.PA.


What is the valuation status of JACQUES BOGART (JBOG.PA) stock?

ChartMill assigns a valuation rating of 2 / 10 to JACQUES BOGART (JBOG.PA). This can be considered as Overvalued.


How profitable is JACQUES BOGART (JBOG.PA) stock?

JACQUES BOGART (JBOG.PA) has a profitability rating of 2 / 10.


What is the financial health of JACQUES BOGART (JBOG.PA) stock?

The financial health rating of JACQUES BOGART (JBOG.PA) is 1 / 10.